Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders. They believe their ability to efficiently discover and develop differentiated drug candidates will allow them to address important unmet medical need with novel oral therapies that can shift immunology markets from injectable
…More to oral drugs. Their current pipeline includes internally discovered clinical programs targeting TYK2, S1P1R and NLRP3, positioning them to become a leader in the development of oral immunology therapies. Ventyx is headquartered in San Diego, California.